IP62-11: Can PSMA PET/CT be used for patients selection in B7-H3-targeted therapy?: Exploration and validation based on bioinformatics, IHC, and molecular imaging

IP62-11: Can PSMA PET/CT be used for patients selection in B7-H3-targeted therapy?: Exploration and validation based on bioinformatics, IHC, and molecular imaging

Sunday, May 17, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Speakers

YL
Yang Luo

Log in

See all the content and easy-to-use features by logging in or registering!